Expansion of Legalized Cannabis Continues at a Torrid Pace in the U.S. and Globally For Leading Markets Worldwide; Company Receives Purchase Order for Medical Marijuana Products
CORAL SPRINGS, Florida, April 20, 2016 /PRNewswire/ --
Global opportunities are promising for legalized marijuana and cannabis sector as revenues continue to thrive behind increased federal & governmental research and development of latest products. Marijuana & Cannabis Companies with current operations and developments of importance in the markets today are New Colombia Resources, Inc. (OTC: NEWC), Cannabis Science, Inc. (OTC: CBIS), Cara Therapeutics (NASDAQ: CARA), Terra Tech Corp. (OTC: TRTC) and Cannabis Sativa Inc. (OTCBB: CBDS).
New Colombia Resources, Inc. (OTC: NEWC), a U.S. company with natural resource assets in Colombia, is pleased to announce that its subsidiary, Sannabis SAS, has received orders from an established pharmacy chain distributing natural products in southwest Colombia. Natural Pharmacy chain Salud Semillas, a leading distributor of natural products with an established customer base in southwest Colombia, has placed an initial purchase order and developed a marketing plan to generate strong sales. In addition to having stores in upscale malls and shopping centers they also sponsor a morning health talk radio show to discuss their featured products. The show targets an area of 350,000 people and attracts 25-35,000 listeners daily from 8-8:30 am. Salud Semillas' marketing plan for Sannabis products includes radio talk shows, telemarketing group, internet sales, newspaper ads, and a direct to customer health magazine called "Buena Vida" which is distributed directly to thousands of customer's homes monthly by Salud Semillas' trained personnel in strategic neighborhoods. For more information on Salud Semillas visit http://www.saludsemillas.com. Their radio show is also broadcast in Spain, France, and Germany as well as online. To listen to the show tune into http://emisora.univalle.edu.co.
Read the full New Colombia Resources (NEWC) press release at: http://www.financialnewsmedia.com/profiles/newc.html
"After 20 years of hard work developing high quality medical marijuana products in Colombia, I'm pleased that we were finally able to establish a mainstream market, our orders are coming in droves," said Juan Pablo Guzman, Director of Sannabis in Colombia. Dr. Robert Melamede Ph.D., scientific advisor to Sannabis and New Colombia Resources, is now in Dubai as a guest speaker at the World Congress on Oncology and Radiology held from April 18-20. He presented at the Novel Approaches to Cancer Therapeutics session. Dr. Melamede is a world renowned expert of the body's Endocannabinoid System and can easily educate world leaders on why cannabis cures and relieves. Dr. Melamede has firsthand knowledge of the effectiveness of Sannabis products in South America and is helping the company establish relationships and purchase orders with Middle Eastern countries. "The cannabis awakening is spreading across the world. The scientific knowledge of the unique healing powers of this plant are now known by more and more people around the world. The truth can no longer be suppressed by ignorance," stated Dr. Robert Melamede, Scientific Advisor to Sannabis and New Colombia Resources.
"In anticipation of having an approved export license, our approach to the international market is simple. You know cannabis cures but you don't want the hurdles of growing marijuana. Our region has grown the best medical strain for generations, we can grow and manufacture the highest quality 100% organic cannabis products for you at the most competitive cost possible. Colombian entrepreneurs are creating a new industry for the legal international medical cannabis and industrial hemp products market and we're proud to be a part of it," commented John Campo President of New Colombia Resources Inc.
In other Cannabis/Legal Marijuana developments: Cannabis Science, Inc. (OTC: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is proud to extend its congratulations to the State of Pennsylvania as the 24th state to legalize cannabis for medical purposes. On Sunday, April 17, 2016, the Governor of Pennsylvania signed into law Senate Bill 3, legalizing medical cannabis consumption. Pennsylvania represents the 24th state to pass such legislation. The U.S. is nearly halfway to full medical legalization. As more states legalize medical cannabis, research and clinical trials can become simpler and less expensive to initiate and maintain.
Cara Therapeutics (NASDAQ: CARA) was mentioned in a recent article published by TheStreet.com as being one of three Marijuana-Related Stocks poised for strong growth. Cara Therapeutics develops chemical substances to treat various degrees of pain is Shelton, Conn. Cara is a clinical-stage biopharmaceutical company that develops and commercializes new drugs that alleviate pain by selectively targeting kappa opioid receptors, a human protein. While GW Pharmaceuticals (NASDAQ: GWPH) - another company mentioned in the article poised for strong growth - primarily treats pain through purified cannabis extracts that bind primarily to cannabinoid receptors in the brain (CB1), Cara boasts a more diverse and bigger portfolio of compounds focused on targeting immune cells (CB2) and unique opioid analgesics. Source: TheStreet.com
Terra Tech Corp. (OTC: TRTC) recently announced that its subsidiary, Edible Garden, a retail seller of locally grown hydroponic produce, herbs, and floral products, has signed an exclusive license agreement with Nutrasorb LLC, a spin-off of Rutgers University, to grow and commercialize nutritionally-enhanced lettuce varieties. Under the terms of the agreement, Edible Garden has the right to grow and sell Green and Red Super Lettuce across the North American and European continents as well as Australia. The produce will be high in vitamins A & C, magnesium, iron and potassium contents. It will also have high levels of fiber and chlorogenic acid. These nutritionally-enhanced, proprietary Green and Red Lettuces were developed by scientists at Rutgers University following years of intensive research.
Cannabis Sativa Inc. (OTCBB: CBDS) announced back in late February that HI Brands International Inc., a wholly owned subsidiary of Cannabis Sativa Inc., has entered into a trademark and licensing agreement with Trike Candy LLC, an Oregon Limited Liability Company to brand hi chocolate bars for the Oregon recreational marijuana market. Trike Candy is licensed to process marijuana infused products in the State of Oregon for sale in the recreational marijuana market.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at financialnewsmedia.com. Follow us on Facebook: facebook.com/financialnewsmedia and Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand nine hundred dollars for news coverage of the current press release issued by New Colombia Resources, Inc. by the company. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information: Company: FN Media Group, LLC Contact email: email@example.com U.S. Phone: +1-(954)345-0611 URL: http://www.financialnewsmedia.com
SOURCE FN Media Group LLC